Supercharging Development of Innovative Platforms for Identification and Validation of Novel Targets Beyond CD19

Time: 3:45 pm
day: Day 2 - Track A - Evening


• Identifying novel targets with potential to develop next generation CAR-TCR therapies with reduced toxic effects of on-target-off-tumour reactivity
• Innovative preclinical and clinical trial designs to maximise patient success
• Exploring new ways to model tumour burden to gain a realistic representation of translation in humans
• Validating pre-clinical models and interpreting data from these models correctly